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KEY FINDINGS

• Fentanyl, a synthetic opioid, is a widespread
additive to heroin in the U.S. Rust Belt.
• Most people who use heroin want to avoid
fentanyl, due to its association with overdose.
• Some people who use prefer fentanyl due to its
shorter, stronger high, even when snorted.
• The ability to identify fentanyl in heroin
through self-test strips might help all users
reduce undesirable effects and overdose risk.

In March 2015, the Drug Enforcement
Administration (DEA) issued a nationwide alert
regarding fentanyl, a potent synthetic opioid
implicated in a surging number of overdose deaths.
Labelling the drug a “significant threat to health
and safety,” the agency warned law enforcement
personnel to take precautions against accidental
exposure, while imploring “parents, caregivers,
and teachers” to educate others on the drug’s
dangers.1 Just six months later, the U.S. Centers for Disease Control sent out a similar advisory, urging
awareness among public health workers and other first responders.2 Neither announcement addressed
illicit opioid users, the population most at risk of fentanyl overdose. Declining to provide practical
advice for fentanyl identification, the alerts further failed to ask whether users wanted to avoid the drug.

Such information and understanding could still prove vital. The year 2017 saw nearly 29,000 fentanylrelated deaths – more than triple the count observed in 2015, when national alarms first began to
sound.3 Amazingly, fentanyl fatalities eclipsed those involving heroin in August 2016, and continued to
climb through mid-2018, even as overall overdose mortality plateaued. Perhaps more surprising is the
drug’s geographic toll. Far from the country’s most notorious heroin markets, fentanyl overdoses have
been concentrated in the Appalachian Rust Belt, devastating West Virginia, Ohio, and Pennsylvania, in
particular. Where the regional opioid epidemic is rooted in deindustrialization, occupational injury, and
easy access to prescription opioids, it has been bolstered by rapidly expanding supplies of first heroin,
then fentanyl. Yet the new availability of illicit opioids has not necessarily led to immediate increases in
substance use services. “Harm reduction” programs – which seek to minimize the risks of illicit drug use
through non-judgmental and pragmatic education – are especially scarce. Faced with limited outlets for
help and information, opioid users may evolve unique techniques for finding, avoiding, and managing
the risks surrounding fentanyl, techniques that may inform broader public health strategies.
In this brief, we summarize findings from a study we conducted in 2017 and 2018 among individuals
who use prescription and illicit opioids in southwestern Pennsylvania, specifically Allegheny, Fayette,
Greene, and Washington counties.4 This region of PA has a much higher fatal drug overdose rate than
the state as a whole. After sporadic outbreaks in the preceding 30 years, fentanyl emerged as a pervasive
additive in drugs sold as heroin in the region in the mid-2010s, a reality that forced local opioid users to
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reevaluate their existing perceptions of “heroin”-related risks – and pleasures. We found that many
individuals attempted to adjust their opioid use habits to minimize the dangers of fentanyl exposure. But
our study also revealed a small, but significant, population of individuals who desired fentanyl for
reasons that reflected their specific life circumstances.
Figure 1: The Southwestern Region of Pennsylvania has among the Highest Fatal
Overdose Rates in the State

Data Source: CDC WONDER Online Database, 2015-175

Most Want to Avoid Fentanyl – But Can’t

A majority of interview participants expressed fears about fentanyl, a substance that they associated
with fast and fatal overdose. Over 80% indicated that they had lost a friend or family member to
overdose at some point in their lives, while nearly one-third said that they had personally experienced
an overdose requiring medical intervention in the past year alone. In recounting recent overdose events
that they had suffered or witnessed, interviewees often suspected the presence of fentanyl in the heroin
they, or others, had consumed. But lacking access to formal toxicology testing, no one could be certain
that fentanyl had in fact caused them to overdose - a reality that constantly undermined their attempts to
avoid overdose. In the absence of reliable testing methods, such as fentanyl testing strips which allow an
individual to know if the drug is present in their batch, individuals who used heroin relied on subjective
indicators to detect fentanyl in the drugs they bought. For example, they would evaluate the color,
consistency, or bodily effects of a bag against their previous experiences. Knowing such methods to be
flawed, some respondents altered their heroin use behaviors in more drastic ways.
When we met in July 2017, Jeffrey, a 46-year-old man from
“I would never buy [heroin] on the
Pittsburgh, was working on giving up opioids after nearly 25
street. Never. You never know what
years of use. He had first tried heroin on a whim in 1993,
you get nowadays.”
when a friend who had typically provided him with cocaine
offered him the opportunity to sample something new. “Oh, I
loved it…and it was cheap,” he said, describing his initiation. Well-connected to the local market,
Jeffrey’s heroin habit lasted over two decades, despite sporadic stints of treatment and prolonged
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periods of abstinence. His job as a long-haul trucker influenced both his desire and ability to successfully
quit. As a member of the Teamster union, Jeffrey enjoyed excellent access to inpatient treatment, but the
nature of his job fueled his opioid cravings: “It is like an eight-hour jog. Your mind’s constantly going if
you wanna get high or not.” Jeffrey was still driving trucks at the time of our interview, however, the toll
of opioid use on his social circle had recently convinced him to renounce heroin. “I went to 12 funerals
this past year and a half. People are dying left and right,” he said, noting that the same person who had
introduced him to heroin in 1993 had recently committed suicide. Jeffrey stressed that, due to fentanyl,
many individuals were vulnerable to overdose after leaving treatment, stating, “I think fentanyl has a lot
to do with it…They’re cutting the heroin with fentanyl.” For this reason, Jeffrey sought out cocaine or
pills whenever he had the urge to use, explaining: “I would never buy [heroin] on the street. Never. You
never know what you get nowadays.”

Others See Benefits to Fentanyl
Unexpectedly, some interview participants reported that they specifically sought out fentanyl, a
substance they saw as having both advantages and disadvantages. Such individuals often described
incidents of overdose that they linked to fentanyl. But ultimately, they identified other ways in which
fentanyl allowed them to manage the many drug-related risks they were tasked with managing every
day. Challenging many stereotypes around who uses fentanyl and why, one couple deemed fentanyl to
be an easier drug to incorporate into their busy work and childcare schedules. Cammie (age24) and
Ryan (age 26) had both begun their opioid use with prescription pain pills before being introduced to
heroin by a mutual co-worker. Soon after, Ryan survived his first, and thus far only, overdose after using
a bag he believed to contain fentanyl – an event that subsequently led the couple to search out the drug
exclusively, as fentanyl became “the only thing that we could do that get us high.”
Beyond experiencing fentanyl as a more pleasurable substance than heroin, Cammie explained that the
drug’s higher potency was a practical necessity given her responsibilities as a mother. Opioid
withdrawal – characterized by debilitating flu-like symptoms – constantly threatened her ability to watch
the couple’s 5-year-old daughter, and fentanyl was most consistent in preventing the onset of sickness:
“I can’t be lying in bed all day. I have a kid. I shouldn’t be doing that, but I feel like I can be a better mom if
I’m not lying in bed, dying all day.” Ryan agreed, remarking that the “sickness is worse on heroin, than
fentanyl,” before stating that fentanyl was a safer drug for somebody like himself who was looking for a
job: “As far as working, taking drug tests and stuff like that, it won’t show up.” Intent upon hiding their
use from both potential employers and family members, Cammie and Ryan both resisted injection, a
practice that might scar them with visible “track marks.” In this respect, fentanyl offered an advantage, as
it could be snorted with more consistent effects than heroin.
Ironically, the couple echoed Jeffrey in worrying about the unpredictability of the illicit drug market.
They couldn’t always guarantee that they would receive fentanyl, and recently it was just “regular, plain
heroin.” Departing from the usual descriptions of fentanyl as a uniquely dangerous drug, Cammie
complained that heroin was “really high risk, because we don’t know what we’re getting, or if its garbage,
or it’s not real. You’re wasting money on it.”
Whatever their opinions about fentanyl, nearly all of the people we spoke with were in agreement about
the need for more and better information when purchasing substances with life-or-death implications.
Emerging research suggests that individuals who use opioids are willing to use of fentanyl self-test trips,
which allow for the advance detection of fentanyl in drugs sold as heroin.6 Our data similarly shows
participant interest in the ability to reliably identify the substances they purchase. Ultimately, fentanyl is
most dangerous when its presence cannot be known and accounted for in practices of drug use.
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Data
This brief draws upon surveys (N=125) and in-depth interviews with 30 individuals residing in
southwestern Pennsylvania who reported prescription opioid misuse or heroin use in the 12 months
prior to the interview. For a more detailed discussion of our study’s methods and findings please see:
https://www.ncbi.nlm.nih.gov/pubmed/30676198.
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